Previous Pause Next
Home >> News Center >> Features >> Appointments >>
Drug Information Association Appoints Kaushik Desai as DIA India Director PDF Print E-mail
User Rating :  / 0
Wednesday, 19 October 2011 00:47
DIA announces the appointment of Kaushik Desai as Director of DIA India. Kaushik brings to DIA both a deep knowledge of the global regulatory framework and the pharmaceutical environment in India as well as a passion for the vision and mission of the association.

Kaushik is a trained pharmacist with more than 25 years of experience in key management positions with multinational and domestic firms. Through 2010, he worked as CEO and Director of Global Pharmatech in Bangalore, where he was responsible for operations, business planning and development, and global quality requirements. He currently serves as Vice President of the Indian Pharmaceutical Association (IPA) and Chairman of the Industrial Pharmacy Division. Kaushik holds a Masters Degree in Pharmacy from Mumbai University and a Diploma in Industrial Management from the Dahanukar Institute of Management.

“We are delighted to have someone of Mr. Desai’s stature and experience to provide leadership to DIA India,” says Paul Pomerantz, DIA Worldwide Executive Director. “He will work closely with the Advisory Council of India to help address the many opportunities in this country.”


DIA is a neutral, global, professional, member-driven association of nearly 18,000 professionals involved in the discovery, development, and life cycle management of pharmaceuticals, biotechnology, medical devices, and related health care products. Through our international educational offerings and myriad networking opportunities, DIA provides a global forum for knowledge exchange that fosters the innovation of products, technologies, and services to improve health and well being worldwide. Headquarters are in Horsham, PA, and Washington, DC USA, with offices in Basel, Switzerland, Tokyo, Japan, Mumbai, India, and Beijing, China.



Add comment  |   Add to my library  |  Forward this article

login to leave comment